Skip to main content

Late Clinical Development of KH176: an innovative orphan drug to reach mitochondrial disease patients & market

Project description

A new drug for mitochondrial diseases

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-2

Coordinator

KHONDRION BV
Net EU contribution
€ 2 336 267,50
Address
Van Heemstraweg 49 E
6641 AA Beuningen
Netherlands

See on map

Region
Oost-Nederland Gelderland Arnhem/Nijmegen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 1 001 257,50